This inventor holds 60 USPTO granted patents, plus 4 CIPO patents and 27 EPO patents, primarily in Inhaler Technology (CPC class A61M). Top assignees: Vectura Delivery Devices Limited, Pixeloptics, Inc., Vectura Gmbh. Active years: 1997-2026.
Inventors with similar research interests:
Location History:
- Newmarket, GB (2014)
- Melbourn Hertfordshire, GB (2015)
- Histon, GB (1997 - 2016)
- Chippenham, GB (2016 - 2019)
- Wiltshire, GB (2022)
- Cambridge, GB (2005 - 2023)
- Cambridgeshire, GB (2006 - 2024)
Company Filing History:
37 out of 54 
7 out of 31 
5 out of 71 
Years Active: 1997-2026
Areas of Expertise:
Title: Roger William Clarke - Innovator in Inhaler Technology
Introduction:
Roger William Clarke, a resident of Cambridge, GB, is a prolific inventor who has made significant contributions in the field of inhaler technology. With an impressive number of 53 patents to his name, Clarke has been instrumental in developing innovative devices for delivering medicaments to patients.
Latest Patents:
One of Clarke's latest inventions is a dry powder inhaler with a blister folding device. This inhaler design includes a housing to accommodate a single blister containing a dose of medicament, a mouthpiece for inhalation, and a blister opening device. The blister support element and blister folding element work in tandem, allowing for easy insertion and extraction of the blister while ensuring efficient drug delivery.
Career Highlights:
Throughout his career, Clarke has worked with industry-leading companies, including Vectura Delivery Devices Limited and Pixeloptics, Inc. These collaborations have provided him with valuable resources and platforms to translate his inventive ideas into practical solutions that benefit patients worldwide.
Collaborations:
During his time at Vectura Delivery Devices Limited, Clarke collaborated closely with colleagues such as Stephen William Eason and Joshua N Haddock. Their combined expertise and shared dedication to advancing inhaler technology have significantly contributed to the success of their projects.
Conclusion:
Roger William Clarke's substantial patent portfolio and industry collaborations reflect his remarkable contributions to the field of inhaler technology. His innovative dry powder inhaler design demonstrates his ability to tackle complex challenges and improve drug delivery systems for better patient outcomes. As Clarke continues to push the boundaries of inhaler technology, we eagerly anticipate further advancements in this crucial aspect of respiratory healthcare.